Participant flow

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · Source last updated 2018-07-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive 1 of 160 possible interventions based on high throughput drug sensitivity assay. antitumor drug screening assay: Undergo high throughput drug sensitivity assay chemotherapy: Patients receive 1 of 160 possible interventions biological therapy: Patients receive 1 of 160 possible interventions 16 patients were enrolled. 14 patients were treated.

   id

   FG000

   title

   Treatment (Chemotherapy, Biological Therapy)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         14

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         14

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice